Fruithy Medical Pty Ltd Report issue

Academic/Hospital Phase 1
Founded: Australia (2019)

Organization Overview

First Clinical Trial
2020
NCT04169256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fruithy Medical Pty Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

bupivacaine (Exparel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1